IONIS PHARMACEUTICALS INC — Director's Dealing 2019

Jul 17, 2019

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: IONIS PHARMACEUTICALS INC (IONS)
CIK: 0000874015
Period of Report: 2019-07-15

Reporting Person: McDevitt Damien (Chief Business Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2019-07-15	Common Stock	M	3542	—	Acquired	3798	Direct
2019-07-15	Common Stock	F	1225	$67.86	Disposed	2573	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2019-07-15	Restricted Stock Units	$	M	3542	Disposed		Common Stock (3542)	Direct

Footnotes

F1: Acquired pursuant to vesting and release of shares pursuant to Restricted Stock Unit ("RSU") awards.

F2: Shares withheld to cover the required tax withholding obligations pursuant to the 2011 Equity Incentive Plan Restricted Stock Unit Agreement and Grant Notice.

F3: Each RSU represents a contingent right to receive one share of Ionis common stock, or its equivalent cash value.

F4: RSUs vest in four equal annual installments. Upon vesting, the RSUs will be paid out in whole shares of Ionis common stock or cash as may be determined by the Company.